Table 1.
Clinical characteristics of the study population
| Mean (SD) | Count (%) | |
|---|---|---|
| Gender | ||
| Male | 54 | 43.5 |
| Female | 70 | 56.5 |
| Esophageal varices | ||
| None | 44 | 35.5 |
| Grade 1 | 22 | 17.7 |
| Grade 2 | 11 | 8.9 |
| Grade 3 | 8 | 6.5 |
| History of variceal bleeding | 9 | 7.3 |
| Active variceal bleeding | 30 | 24.2 |
| MELD-Na groups | ||
| <10 | 37 | 30.1 |
| 10–19 | 45 | 36.6 |
| 20–29 | 23 | 18.7 |
| 30–40 | 18 | 14.6 |
| CTP class | ||
| A | 29 | 23.4 |
| B | 59 | 47.6 |
| C | 36 | 29 |
| Cirrhosis stage | ||
| Stage 1 | 19 | 15.3 |
| Stage 2 | 37 | 29.8 |
| Stage 3 | 31 | 25 |
| Stage 4 | 37 | 29.8 |
CTP: Child-Turcotte-Pugh; MELD-Na: Model for End-stage Liver Disease-serum sodium modification.